JP6132656B2 - Method for producing picene and derivatives thereof - Google Patents
Method for producing picene and derivatives thereof Download PDFInfo
- Publication number
- JP6132656B2 JP6132656B2 JP2013101582A JP2013101582A JP6132656B2 JP 6132656 B2 JP6132656 B2 JP 6132656B2 JP 2013101582 A JP2013101582 A JP 2013101582A JP 2013101582 A JP2013101582 A JP 2013101582A JP 6132656 B2 JP6132656 B2 JP 6132656B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compounds
- carbon atoms
- compound
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- GBROPGWFBFCKAG-UHFFFAOYSA-N picene Chemical compound C1=CC2=C3C=CC=CC3=CC=C2C2=C1C1=CC=CC=C1C=C2 GBROPGWFBFCKAG-UHFFFAOYSA-N 0.000 title claims description 90
- 238000004519 manufacturing process Methods 0.000 title claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 65
- 125000004432 carbon atom Chemical group C* 0.000 claims description 42
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 125000001424 substituent group Chemical group 0.000 claims description 27
- 150000002430 hydrocarbons Chemical group 0.000 claims description 24
- 150000003623 transition metal compounds Chemical class 0.000 claims description 23
- 125000005843 halogen group Chemical group 0.000 claims description 21
- -1 tri-substituted phosphine Chemical class 0.000 claims description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 239000002585 base Substances 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- 150000003003 phosphines Chemical class 0.000 claims description 10
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 10
- 150000002941 palladium compounds Chemical class 0.000 claims description 8
- 239000005749 Copper compound Substances 0.000 claims description 6
- 229940045985 antineoplastic platinum compound Drugs 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 150000001869 cobalt compounds Chemical class 0.000 claims description 6
- 150000001880 copper compounds Chemical class 0.000 claims description 6
- 150000002344 gold compounds Chemical class 0.000 claims description 6
- 150000002504 iridium compounds Chemical class 0.000 claims description 6
- 150000002506 iron compounds Chemical class 0.000 claims description 6
- 150000002816 nickel compounds Chemical class 0.000 claims description 6
- 150000003058 platinum compounds Chemical class 0.000 claims description 6
- 150000003284 rhodium compounds Chemical class 0.000 claims description 6
- 150000003304 ruthenium compounds Chemical class 0.000 claims description 6
- 229940100890 silver compound Drugs 0.000 claims description 6
- 150000003379 silver compounds Chemical class 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 3
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000004065 semiconductor Substances 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- NYIUJMHFHZDKSI-UHFFFAOYSA-N 1,4-dichloro-2,3-diiodobenzene Chemical compound ClC1=CC=C(Cl)C(I)=C1I NYIUJMHFHZDKSI-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000010409 thin film Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 230000005669 field effect Effects 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000006161 Suzuki-Miyaura coupling reaction Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 229940126543 compound 14 Drugs 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 239000012300 argon atmosphere Substances 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 235000011118 potassium hydroxide Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 5
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 3
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 3
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 3
- PUDWVBJTAVFUFB-UHFFFAOYSA-N 1,4-dibromo-2,3-diiodobenzene Chemical compound BrC1=CC=C(Br)C(I)=C1I PUDWVBJTAVFUFB-UHFFFAOYSA-N 0.000 description 3
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 3
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 3
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- 0 Cc1cccc(*)c1 Chemical compound Cc1cccc(*)c1 0.000 description 3
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 3
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 229940125758 compound 15 Drugs 0.000 description 3
- 229940126142 compound 16 Drugs 0.000 description 3
- 229940126086 compound 21 Drugs 0.000 description 3
- 229940126208 compound 22 Drugs 0.000 description 3
- 229940125961 compound 24 Drugs 0.000 description 3
- 229940125846 compound 25 Drugs 0.000 description 3
- 229940125851 compound 27 Drugs 0.000 description 3
- 229940125877 compound 31 Drugs 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KYLUAQBYONVMCP-UHFFFAOYSA-N (2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P KYLUAQBYONVMCP-UHFFFAOYSA-N 0.000 description 2
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- MYKJZXRWDIWMDR-KTKRTIGZSA-N 2-[(Z)-2-(3-methoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound COC=1C=C(C=CC=1)\C=C/B1OC(C(O1)(C)C)(C)C MYKJZXRWDIWMDR-KTKRTIGZSA-N 0.000 description 2
- CSIFGMFVGDBOQC-UHFFFAOYSA-N 3-iminobutanenitrile Chemical compound CC(=N)CC#N CSIFGMFVGDBOQC-UHFFFAOYSA-N 0.000 description 2
- LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical compound CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 description 2
- KPUHZJKMHCMBQD-UHFFFAOYSA-N 5,8-diethylpicene Chemical compound CCc1cc2c(ccc3c4ccccc4c(CC)cc23)c2ccccc12 KPUHZJKMHCMBQD-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- FHJSTZJVZGUKND-HNENSFHCSA-N B1(OC(C(O1)(C)C)(C)C)/C=C\C2=CC=CC(=C2)CCCCCCCCCC Chemical compound B1(OC(C(O1)(C)C)(C)C)/C=C\C2=CC=CC(=C2)CCCCCCCCCC FHJSTZJVZGUKND-HNENSFHCSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- DLIJPAHLBJIQHE-UHFFFAOYSA-N butylphosphane Chemical compound CCCCP DLIJPAHLBJIQHE-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 125000003963 dichloro group Chemical group Cl* 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 description 2
- DZQQRNFLQBSVBN-UHFFFAOYSA-N tri(butan-2-yl)phosphane Chemical compound CCC(C)P(C(C)CC)C(C)CC DZQQRNFLQBSVBN-UHFFFAOYSA-N 0.000 description 2
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 2
- FPZZZGJWXOHLDJ-UHFFFAOYSA-N trihexylphosphane Chemical compound CCCCCCP(CCCCCC)CCCCCC FPZZZGJWXOHLDJ-UHFFFAOYSA-N 0.000 description 2
- KCTAHLRCZMOTKM-UHFFFAOYSA-N tripropylphosphane Chemical compound CCCP(CCC)CCC KCTAHLRCZMOTKM-UHFFFAOYSA-N 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- PDJQCHVMABBNQW-MIXQCLKLSA-L (1z,5z)-cycloocta-1,5-diene;rhodium;dichloride Chemical compound [Cl-].[Cl-].[Rh].[Rh].C\1C\C=C/CC\C=C/1.C\1C\C=C/CC\C=C/1 PDJQCHVMABBNQW-MIXQCLKLSA-L 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- CZICLKKAVOBWSW-UHFFFAOYSA-N 1,2-selenazole Chemical group C=1C=N[se]C=1 CZICLKKAVOBWSW-UHFFFAOYSA-N 0.000 description 1
- SFPQFQUXAJOWNF-UHFFFAOYSA-N 1,3-diiodobenzene Chemical compound IC1=CC=CC(I)=C1 SFPQFQUXAJOWNF-UHFFFAOYSA-N 0.000 description 1
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical group C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 1
- PYWQACMPJZLKOQ-UHFFFAOYSA-N 1,3-tellurazole Chemical group [Te]1C=CN=C1 PYWQACMPJZLKOQ-UHFFFAOYSA-N 0.000 description 1
- GIIKQOKCBNRAKI-UHFFFAOYSA-N 2,4,9,11-tetramethoxypicene Chemical compound COc1cc(OC)c2ccc3c4ccc5c(OC)cc(OC)cc5c4ccc3c2c1 GIIKQOKCBNRAKI-UHFFFAOYSA-N 0.000 description 1
- NZMQBBONGUIHTM-UHFFFAOYSA-N 3,10-didecylpicene Chemical compound C1=CC2=C3C=CC(CCCCCCCCCC)=CC3=CC=C2C2=C1C1=CC=C(CCCCCCCCCC)C=C1C=C2 NZMQBBONGUIHTM-UHFFFAOYSA-N 0.000 description 1
- RLDUAGYSGIKHKK-UHFFFAOYSA-N 3,10-dimethoxypicene Chemical compound C1=CC2=C3C=CC(OC)=CC3=CC=C2C2=C1C1=CC=C(OC)C=C1C=C2 RLDUAGYSGIKHKK-UHFFFAOYSA-N 0.000 description 1
- UCFSYHMCKWNKAH-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OBOC1(C)C UCFSYHMCKWNKAH-UHFFFAOYSA-N 0.000 description 1
- KGDIKUAFUAQZNF-SEYXRHQNSA-N 4,4,5,5-tetramethyl-2-[(z)-2-phenylbut-1-enyl]-1,3,2-dioxaborolane Chemical compound C=1C=CC=CC=1C(/CC)=C\B1OC(C)(C)C(C)(C)O1 KGDIKUAFUAQZNF-SEYXRHQNSA-N 0.000 description 1
- TZODQUBLEMDCLX-WAYWQWQTSA-N B/C=C\c1cccc(OC)c1 Chemical compound B/C=C\c1cccc(OC)c1 TZODQUBLEMDCLX-WAYWQWQTSA-N 0.000 description 1
- FRYRJNHMRVINIZ-UHFFFAOYSA-N B1CCOO1 Chemical compound B1CCOO1 FRYRJNHMRVINIZ-UHFFFAOYSA-N 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 125000005620 boronic acid group Chemical class 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- PODDMJATAWBBPI-UHFFFAOYSA-N chlorosilyl(trimethyl)silane Chemical compound C[Si](C)(C)[SiH2]Cl PODDMJATAWBBPI-UHFFFAOYSA-N 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004914 dipropylamino group Chemical group C(CC)N(CCC)* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001245 hexylamino group Chemical group [H]N([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N o-dihydroxy-benzene Natural products OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- MABNMNVCOAICNO-UHFFFAOYSA-N selenophene Chemical group C=1C=C[se]C=1 MABNMNVCOAICNO-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
- Y02P70/50—Manufacturing or production processes characterised by the final manufactured product
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Photovoltaic Devices (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Description
本発明は、有機半導体、有機薄膜トランジスタ、有機電界効果トランジスタ又は有機太陽電池等の用途に利用することのできるピセン及びその誘導体の製造方法を提供するものである。さらには、これらの用途に有用性が高まっているピセン及びその誘導体を短い反応工程により収率よく製造する方法を提供するものである。 The present invention provides a method for producing picene and derivatives thereof that can be used in applications such as organic semiconductors, organic thin film transistors, organic field effect transistors, or organic solar cells. Furthermore, the present invention provides a method for producing picene and derivatives thereof, which are increasingly useful for these applications, with a short reaction process with high yield.
有機半導体材料として、従来ペンタセンが知られており、特許文献1及び2には、ペンタセンを有機半導体として利用することが提案されている。ところが、ペンタセンは大気中での安定性が低いという欠点がある。そこで、ピセンのようにベンゼン環が折れ曲がった構造の縮合芳香環を用いた有機TFTが非特許文献1にて報告されている。ピセンはペンタセンよりもイオン化ポテンシャルが低いため化合物の大気中での酸化安定性に優れることが記載されており、有機半導体として利用する際にはきわめて有利といえる。
また、特許文献3の実施例1によれば、5工程の反応により、3%の収率でピセンを合成し、特許文献3の実施例1のもう一つの実験によれば、3工程の反応により5%の収率でピセンを合成しているが、工程数が多く且つ収率も低いので、合理的とはいえない。
Conventionally, pentacene is known as an organic semiconductor material, and Patent Documents 1 and 2 propose use of pentacene as an organic semiconductor. However, pentacene has a drawback of low stability in the atmosphere. Therefore, Non-Patent Document 1 reports an organic TFT using a condensed aromatic ring having a structure in which a benzene ring is bent like picene. Since picene has a lower ionization potential than pentacene, it is described that the compound has excellent oxidation stability in the atmosphere, and can be said to be extremely advantageous when used as an organic semiconductor.
According to Example 1 of Patent Document 3, picene was synthesized in a yield of 3% by a 5-step reaction. According to another experiment of Example 1 of Patent Document 3, a 3-step reaction was performed. The synthesis of picene with a yield of 5% is not reasonable because of the large number of steps and low yield.
従って、本発明の目的は、有機半導体、有機薄膜トランジスタ、有機電界効果トランジスタ又は有機太陽電池等の用途に有用性が高まっているピセン及びその誘導体を、短い反応工程により収率よく製造する方法を提供することにある。
また、本発明の別の目的は、ピセン及びその誘導体の中間体として有用な新規化合物を提供することにある。
Accordingly, an object of the present invention is to provide a method for producing picene and derivatives thereof, which are increasingly useful in applications such as organic semiconductors, organic thin film transistors, organic field effect transistors, or organic solar cells, in a high yield by a short reaction process. There is to do.
Another object of the present invention is to provide a novel compound useful as an intermediate for picene and its derivatives.
本発明者は、上記目的を達成するために、鋭意検討した結果、下記一般式(2)及び下記一般式(3)で表される化合物から2工程でもって高収率でピセン及びその誘導体を製造することができることを見い出し、本発明を完成した。
即ち、本発明は、下記[1]〜[13]に関する。
本発明によれば、僅か2工程の反応により比較的高収率でピセン及びその誘導体を製造することができる。また、本発明によれば、穏和な条件下で、高い収率でもってピセン及びその誘導体を製造できるという特徴がある。
本発明で製造されたピセン及びその誘導体は、有機半導体、電界効果トランジスタ、有機薄膜トランジスタ、有機薄膜太陽電池等の用途に使用できる。
本発明で製造されたピセン及びその誘導体は、ペンタセンよりもイオン化ポテンシャルが低いため化合物の大気中での酸化安定性に優れており、有機半導体として利用する際にはきわめて有利である。
As a result of intensive studies to achieve the above object, the present inventor obtained picene and its derivatives in a high yield in two steps from the compounds represented by the following general formula (2) and the following general formula (3). The present invention has been completed by finding that it can be manufactured.
That is, the present invention relates to the following [1] to [13].
According to the present invention, picene and its derivatives can be produced in a relatively high yield by a reaction of only two steps. In addition, according to the present invention, picene and its derivatives can be produced with a high yield under mild conditions.
The picene and its derivative manufactured by this invention can be used for uses, such as an organic semiconductor, a field effect transistor, an organic thin-film transistor, and an organic thin-film solar cell.
The picene and its derivatives produced in the present invention have a lower ionization potential than pentacene, so that the oxidation stability of the compound in the atmosphere is excellent, and it is extremely advantageous when used as an organic semiconductor.
[1] 下記一般式(2)で表される化合物(b)と下記一般式(3)で表される化合物(c)とを、カップリング反応させることにより、下記一般式(1)で表される化合物(a)を製造する工程1と、
下記一般式(1)で表される化合物(a)を脱ハロゲン化水素させる工程2とを含むことを特徴とする下記一般式(4)で表されるピセン及びその誘導体の製造方法。
[1] A compound (b) represented by the following general formula (2) and a compound (c) represented by the following general formula (3) are subjected to a coupling reaction, thereby being represented by the following general formula (1). Step 1 for producing the compound (a) to be produced;
And a process 2 for dehydrohalogenating the compound (a) represented by the following general formula (1), and a method for producing a picene represented by the following general formula (4) and a derivative thereof.
[2] 工程1の反応を、遷移金属化合物とトリ置換ホスフィンからなる触媒と塩基の存在下に行う[1]に記載のピセン及びその誘導体の製造方法。
[3] 工程1で用いる遷移金属化合物が、パラジウム化合物、ロジウム化合物、白金化合物、ニッケル化合物、コバルト化合物、銅化合物、鉄化合物、イリジウム化合物、ルテニウム化合物、銀化合物及び金化合物からなる群から選ばれた少なくとも1種の遷移金属化合物である[2]に記載のピセン及びその誘導体の製造方法。
[4] 工程1で用いるトリ置換ホスフィンが、トリアルキルホスフィン及びトリアリールホスフィンからなる群から選ばれた少なくとも1種のトリ置換ホスフィンである[2]又は[3]に記載のピセン及びその誘導体の製造方法。
[5] 工程1で用いる塩基が水酸化カリウム又は水酸化ナトリウムである[2]〜[4]の何れかに記載のピセン及びその誘導体の製造方法。
[2] The process for producing picene and derivatives thereof according to [1], wherein the reaction in step 1 is performed in the presence of a catalyst comprising a transition metal compound and a tri-substituted phosphine and a base.
[3] The transition metal compound used in Step 1 is selected from the group consisting of palladium compounds, rhodium compounds, platinum compounds, nickel compounds, cobalt compounds, copper compounds, iron compounds, iridium compounds, ruthenium compounds, silver compounds and gold compounds. The method for producing picene and derivatives thereof according to [2], which is at least one transition metal compound.
[4] The picene and the derivative thereof according to [2] or [3], wherein the trisubstituted phosphine used in Step 1 is at least one trisubstituted phosphine selected from the group consisting of trialkylphosphine and triarylphosphine. Production method.
[5] The method for producing picene and derivatives thereof according to any one of [2] to [4], wherein the base used in step 1 is potassium hydroxide or sodium hydroxide.
[6] 工程2の反応を、遷移金属化合物とトリ置換ホスフィンからなる触媒と塩基の存在下に行う[1]又は[2]に記載のピセン及びその誘導体の製造方法。
[7] 工程2で用いる遷移金属化合物が、パラジウム化合物、ロジウム化合物、白金化合物、ニッケル化合物、コバルト化合物、銅化合物、鉄化合物、イリジウム化合物、ルテニウム化合物、銀化合物及び金化合物からなる群から選ばれた少なくとも1種の遷移金属化合物である[6]に記載のピセン及びその誘導体の製造方法。
[8] 工程2で用いるトリ置換ホスフィンが、トリシクロアルキルホスフィン、トリアルキルホスフィン及びトリアリールホスフィンからなる群から選ばれた少なくとも1種のトリ置換ホスフィンである[6]又は[7]に記載のピセン及びその誘導体の製造方法。
[9]工程2で用いる塩基がアルカリ金属炭酸塩である[6]〜[8]の何れかに記載のピセン及びその誘導体の製造方法。
[6] The process for producing picene and derivatives thereof according to [1] or [2], wherein the reaction of step 2 is performed in the presence of a catalyst comprising a transition metal compound and trisubstituted phosphine and a base.
[7] The transition metal compound used in step 2 is selected from the group consisting of palladium compounds, rhodium compounds, platinum compounds, nickel compounds, cobalt compounds, copper compounds, iron compounds, iridium compounds, ruthenium compounds, silver compounds and gold compounds. The method for producing picene and derivatives thereof according to [6], which is at least one transition metal compound.
[8] The trisubstituted phosphine used in Step 2 is at least one trisubstituted phosphine selected from the group consisting of a tricycloalkylphosphine, a trialkylphosphine, and a triarylphosphine, according to [6] or [7] A process for producing picene and its derivatives.
[9] The method for producing picene and derivatives thereof according to any one of [6] to [8], wherein the base used in step 2 is an alkali metal carbonate.
[10] [1]〜[9]の何れかに記載の製造方法により製造されたピセン及びその誘導体を含んでなる有機半導体。
[11] [1]〜[9]の何れかに記載の製造方法により製造されたピセン及びその誘導体を含んでなる電界効果トランジスタ。
[12] [1]〜[9]の何れかに記載の製造方法により製造されたピセン及びその誘導体を含んでなる太陽電池。
[10] An organic semiconductor comprising picene produced by the production method according to any one of [1] to [9] and a derivative thereof.
[11] A field effect transistor comprising picene produced by the production method according to any one of [1] to [9] and a derivative thereof.
[12] A solar cell comprising picene produced by the production method according to any one of [1] to [9] and a derivative thereof.
[13] 下記一般式(1)で表される化合物。 [13] A compound represented by the following general formula (1).
本発明によれば、少ない工程数、穏和な条件下で、ピセン及びその誘導体を高収率で製造できるという特徴がある。
本発明で製造されたピセン及びその誘導体は、有機半導体、電界効果トランジスタ、有機薄膜トランジスタ、有機薄膜太陽電池等の用途に使用できる。
本発明で製造されたピセン及びその誘導体は、ペンタセンよりもイオン化ポテンシャルが低いため化合物の大気中での酸化安定性に優れており、有機半導体として利用する際にはきわめて有利である。
According to the present invention, picene and its derivatives can be produced in a high yield under a small number of steps and mild conditions.
The picene and its derivative manufactured by this invention can be used for uses, such as an organic semiconductor, a field effect transistor, an organic thin-film transistor, and an organic thin-film solar cell.
The picene and its derivatives produced in the present invention have a lower ionization potential than pentacene, so that the oxidation stability of the compound in the atmosphere is excellent, and it is extremely advantageous when used as an organic semiconductor.
以下、本発明を詳細に説明するが、本発明はこれらに限定されるものではない。
先ず、本発明の製造方法について説明する。
<工程1:ハロゲン置換前駆体の合成>
工程1では、下記一般式(2)で表される化合物(b)と下記一般式(3)で表される化合物(c)とを、カップリング反応させることにより、下記一般式(1)で表される化合物(a)が製造される。
Hereinafter, the present invention will be described in detail, but the present invention is not limited thereto.
First, the production method of the present invention will be described.
<Step 1: Synthesis of halogen-substituted precursor>
In step 1, a compound (b) represented by the following general formula (2) and a compound (c) represented by the following general formula (3) are subjected to a coupling reaction, whereby the following general formula (1) The compound (a) represented is produced.
上記一般式(1)及び(3)において、Arはアリール基を表し、アリール基としては、芳香族炭化水素環又は芳香族複素環が挙げられる。
芳香族炭化水素環としては、ベンゼン環等が挙げられ、芳香族複素環としては、チオフェン環、フラン環、セレノフェン環、テルロフェン環、ピロール環、イミダゾール環、ピラゾール環、テルラゾール環、イソテルラゾール環、セレナゾール環、イソセレナゾール環、チアゾール環、イソチアゾール環、オキサゾール環、イソオキサゾール環、フラザン環等が挙げられる。
In the general formulas (1) and (3), Ar represents an aryl group, and examples of the aryl group include an aromatic hydrocarbon ring and an aromatic heterocycle.
Examples of the aromatic hydrocarbon ring include a benzene ring, and examples of the aromatic heterocycle include a thiophene ring, a furan ring, a selenophene ring, a tellurophen ring, a pyrrole ring, an imidazole ring, a pyrazole ring, a tellurazole ring, and an isotelrazole ring. , A selenazole ring, an isoselenazole ring, a thiazole ring, an isothiazole ring, an oxazole ring, an isoxazole ring, a furazane ring, and the like.
上記一般式(1)〜(3)において、R5、R6、R7及びR8は、具体的にはそれぞれ独立に水素原子、ハロゲン原子、ニトロ基、保護されていてもよい水酸基、保護されていてもよいアミノ基、保護されるか又は塩を形成していてもよいカルボキシル基、置換基を有していてもよい炭素数1〜20の炭化水素基、置換基を有していてもよい炭素数1〜20のアルコキシ基又は−SiR13R14R15で表される基を示し、R13、R14及びR15はそれぞれ独立に水素原子又は置換基を有していてもよい炭素数1〜20の炭化水素基を示す。また、X1及びX2は、ハロゲン原子を示す。
ハロゲン原子としては、フッ素、塩素、臭素、ヨウ素等が挙げられ、保護されていてもよい水酸基としては、水酸基のほか、アセチルオキシ基、プロピオニルオキシ基、アクリロイル基、メタアクリロイル基等の炭素数1〜20のアルキルカルボニルオキシ基を例示することができる。保護されていてもよいアミノ基としては、エチルアミノ基、プロピルアミノ基、ジエチルアミノ基、ジプロピルアミノ基、ヘキシルアミノ基、ジシクロペンチルアミノ基等の炭素数が1〜20の置換基を有していてもよいアミノ基を例示することができる。保護されるか又は塩を形成していてもよいカルボキシル基としては、カルボキシル基、カルボキシル基が各種の塩基と形成したカルボン酸塩、各種アルコールと形成した炭素数1〜20のエステル等を例示することができる。置換基を有していてもよい炭素数1〜20の炭化水素基としては、メチル基、エチル基、プロピル基、プロペニル基、ブチル基、ブテニル基、ペンチル基、ヘキシル基、シクロペンチル基、シクロヘキシル基、シクロへキセニル基等の炭化水素基及びこれらの炭化水素基が置換された基等を例示することができる。置換基を有していてもよい炭素数1〜20のアルコキシ基としては、メトキシ基、エトキシ基、プロポキシ基、ブトキシ基等のアルコキシ基及びこれらのアルコキシ基が置換された基等を例示することができる。
BR11R12としては、ボロン酸、ボロン酸カテコールエステル、ボロン酸ピナコールエステル等の各種のボロン酸及びそのエステル残基を例示することができる。R11及びR12は前記と同一である。R11及びR12は環を形成してもよい。
In the general formulas (1) to (3), R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom, a halogen atom, a nitro group, an optionally protected hydroxyl group or a protected group. An amino group which may be protected, a carboxyl group which may be protected or form a salt, a hydrocarbon group having 1 to 20 carbon atoms which may have a substituent, and a substituent; A C 1-20 alkoxy group or a group represented by —SiR 13 R 14 R 15 , wherein R 13 , R 14 and R 15 may each independently have a hydrogen atom or a substituent; A hydrocarbon group having 1 to 20 carbon atoms is shown. X 1 and X 2 each represent a halogen atom.
Examples of the halogen atom include fluorine, chlorine, bromine, iodine, etc. The hydroxyl group which may be protected includes, in addition to the hydroxyl group, carbon number 1 such as acetyloxy group, propionyloxy group, acryloyl group, methacryloyl group and the like. ˜20 alkylcarbonyloxy groups can be exemplified. The amino group which may be protected has a substituent having 1 to 20 carbon atoms such as ethylamino group, propylamino group, diethylamino group, dipropylamino group, hexylamino group and dicyclopentylamino group. The amino group which may be sufficient can be illustrated. Examples of the carboxyl group that may be protected or may form a salt include carboxyl groups, carboxylates formed by carboxyl groups with various bases, esters having 1 to 20 carbon atoms formed with various alcohols, and the like. be able to. Examples of the optionally substituted hydrocarbon group having 1 to 20 carbon atoms include methyl group, ethyl group, propyl group, propenyl group, butyl group, butenyl group, pentyl group, hexyl group, cyclopentyl group, and cyclohexyl group. And a hydrocarbon group such as a cyclohexenyl group and a group in which these hydrocarbon groups are substituted. Examples of the alkoxy group having 1 to 20 carbon atoms which may have a substituent include alkoxy groups such as a methoxy group, an ethoxy group, a propoxy group and a butoxy group, and groups in which these alkoxy groups are substituted. Can do.
Examples of BR 11 R 12 include various boronic acids such as boronic acid, boronic acid catechol ester, and boronic acid pinacol ester, and ester residues thereof. R 11 and R 12 are the same as described above. R 11 and R 12 may form a ring.
上記一般式(2)で表される化合物(b)としては、以下の化合物が好ましい。
R7及びR8が水素原子又は炭素数1〜20の炭化水素基である化合物。
X1及びX2が塩素原子、臭素原子、ヨウ素原子である化合物。
また、上記一般式(3)で表される化合物(c)としては、以下の化合物が好ましい。
Arの水素原子が置換されていない化合物、又は、Arの水素原子が炭素数1〜20の炭化水素基、保護されている水酸基(特に、炭素数1〜20の炭化水素基により保護されている水酸基)若しくは−SiR13R14R15で表される基により置換されている化合物。
R5及びR6が水素原子又は炭素数1〜20の炭化水素基である化合物。
BR11R12で表される基が、ボロン酸ピナコールエステルである化合物。
従って、上記一般式(1)で表される化合物(a)としては、以下の化合物が好ましい。
Arの水素原子が置換されていない化合物、又は、Arの水素原子が炭素数1〜20の炭化水素基、保護されている水酸基(特に、炭素数1〜20の炭化水素基により保護されている水酸基)若しくは−SiR13R14R15で表される基により置換されている化合物。
R5及びR6が水素原子又は炭素数1〜20の炭化水素基である化合物。
R7及びR8が水素原子又は炭素数1〜20の炭化水素基である化合物。
X1が塩素原子、臭素原子、ヨウ素原子である化合物。
As the compound (b) represented by the general formula (2), the following compounds are preferable.
The compound whose R < 7 > and R < 8 > is a hydrogen atom or a C1-C20 hydrocarbon group.
A compound in which X 1 and X 2 are a chlorine atom, a bromine atom, or an iodine atom.
Moreover, as a compound (c) represented by the said General formula (3), the following compounds are preferable.
A compound in which the hydrogen atom of Ar is not substituted, or the hydrogen atom of Ar is protected by a hydrocarbon group having 1 to 20 carbon atoms or a protected hydroxyl group (particularly, protected by a hydrocarbon group having 1 to 20 carbon atoms) A compound substituted with a group represented by (hydroxyl group) or —SiR 13 R 14 R 15 .
A compound in which R 5 and R 6 are a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms.
A compound in which the group represented by BR 11 R 12 is a boronic acid pinacol ester.
Therefore, the following compounds are preferred as the compound (a) represented by the general formula (1).
A compound in which the hydrogen atom of Ar is not substituted, or the hydrogen atom of Ar is protected by a hydrocarbon group having 1 to 20 carbon atoms or a protected hydroxyl group (particularly, protected by a hydrocarbon group having 1 to 20 carbon atoms) A compound substituted with a group represented by (hydroxyl group) or —SiR 13 R 14 R 15 .
A compound in which R 5 and R 6 are a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms.
The compound whose R < 7 > and R < 8 > is a hydrogen atom or a C1-C20 hydrocarbon group.
A compound in which X 1 is a chlorine atom, a bromine atom, or an iodine atom.
<工程1の反応及び反応条件>
工程1の反応は、上記一般式(2)で表される化合物(b)と上記一般式(3)で表される化合物(c)とのカップリング反応を、遷移金属化合物とトリ置換ホスフィンからなる触媒と塩基の存在下に実施する。
上記一般式(2)で表される化合物(b)と上記一般式(3)で表される化合物(c)の使用量は、上記一般式(2)で表される化合物(b)に対するモル比として通常0.3〜3.0、好ましくは0.5〜2.0である。
上記遷移金属化合物としては、パラジウム化合物、ロジウム化合物、白金化合物、ニッケル化合物、コバルト化合物、銅化合物、鉄化合物、イリジウム化合物、ルテニウム化合物、銀化合物、金化合物からなる群から選ばれた少なくとも1種の遷移金属化合物が例示される。遷移金属化合物は、上述した各化合物のハロゲン化物、硝酸塩、酢酸塩、アセチルアセトナート錯体等であってもよい。
上記遷移金属化合物の中でも、活性の点から、パラジウム化合物が好ましい。
上記トリ置換ホスフィンとしては、トリtert-ブチルホスフィン、トリsec-ブチルホスフィン、n-ブチルホスフィン、トリプロピルホスフィン、トリヘキシルホスフィン等のトリアルキルホスフィン、トリシクロヘキシルホスフィン等のトリシクロアルキルホスフィン、トリフェニルホスフィン、トリトリルホスフィン等のトリアリールホスフィンを例示することができる。
上記塩基としては、水酸化カリウム又は水酸化ナトリウムが好適に使用される。塩基の使用量は、上記一般式(2)で表される化合物(b)に対するモル比として1〜20、好ましくは3〜8である。
工程1の反応は、通常、溶媒の存在下に実施される。溶媒としては、ジエチルエーテル、テトラヒドロフラン、ジオキサン等のエーテルが通常使用され、その使用量は適宜である。
工程1の反応は、通常−20〜70℃、好ましくは0〜50℃の温度で実施され、反応時間は通常1〜50時間、好ましくは3〜30時間である。
<Reaction and reaction conditions in step 1>
The reaction in Step 1 is carried out by performing a coupling reaction between the compound (b) represented by the general formula (2) and the compound (c) represented by the general formula (3) from a transition metal compound and a trisubstituted phosphine. In the presence of a catalyst and a base.
The usage-amount of the compound (b) represented by the said General formula (2) and the compound (c) represented by the said General formula (3) is the mole with respect to the compound (b) represented by the said General formula (2). The ratio is usually 0.3 to 3.0, preferably 0.5 to 2.0.
The transition metal compound is at least one selected from the group consisting of palladium compounds, rhodium compounds, platinum compounds, nickel compounds, cobalt compounds, copper compounds, iron compounds, iridium compounds, ruthenium compounds, silver compounds, and gold compounds. Transition metal compounds are exemplified. The transition metal compound may be a halide, nitrate, acetate, acetylacetonate complex or the like of each compound described above.
Among the transition metal compounds, palladium compounds are preferable from the viewpoint of activity.
Examples of the tri-substituted phosphine include tritert-butylphosphine, trisec-butylphosphine, n-butylphosphine, tripropylphosphine, trihexylphosphine, etc. And triarylphosphine such as tolylphosphine.
As the base, potassium hydroxide or sodium hydroxide is preferably used. The usage-amount of a base is 1-20 as a molar ratio with respect to the compound (b) represented by the said General formula (2), Preferably it is 3-8.
The reaction of Step 1 is usually performed in the presence of a solvent. As the solvent, ethers such as diethyl ether, tetrahydrofuran, and dioxane are usually used, and the amount used is appropriate.
Reaction of the process 1 is normally implemented at the temperature of -20-70 degreeC, Preferably it is 0-50 degreeC, and reaction time is 1 to 50 hours normally, Preferably it is 3 to 30 hours.
<工程2:ピセン及びその誘導体の合成>
工程2では、上記一般式(1)で表される化合物(a)を脱ハロゲン化水素させることにより、下記一般式(4)で表されるピセン及びその誘導体が製造される。
<Step 2: Synthesis of picene and derivatives thereof>
In step 2, picene and its derivative represented by the following general formula (4) are produced by dehydrohalogenating the compound (a) represented by the above general formula (1).
上記一般式(4)において、Ar,R5,R6,R7及びR8の表す基としては、工程1における例示と同じものが挙げられる。 In the general formula (4), examples of the group represented by Ar, R 5 , R 6 , R 7 and R 8 are the same as those exemplified in Step 1.
<工程2の反応及び反応条件>
工程2の反応は、遷移金属化合物とトリ置換ホスフィンからなる触媒と塩基の存在下に実施される。
上記遷移金属化合物としては、パラジウム化合物、ロジウム化合物、白金化合物、ニッケル化合物、コバルト化合物、銅化合物、鉄化合物、イリジウム化合物、ルテニウム化合物、銀化合物、金化合物からなる群から選ばれた少なくとも1種の遷移金属化合物が例示される。遷移金属化合物は、上述した各化合物のハロゲン化物、硝酸塩、酢酸塩、アセチルアセトナート錯体等であってもよい。
上記トリ置換ホスフィンとしては、トリtert-ブチルホスフィン、トリsec-ブチルホスフィン、n-ブチルホスフィン、トリプロピルホスフィン、トリヘキシルホスフィン等のトリアルキルホスフィン、トリシクロヘキシルホスフィン等のトリシクロアルキルホスフィン、トリフェニルホスフィン、トリトリルホスフィン等のトリアリールホスフィンを例示することができる。
上記遷移金属化合物の中でも、活性の点から、パラジウム化合物が好ましい。
上記塩基としては、アルカリ金属炭酸塩又はアルカリ土類金属炭酸塩を好適に用いることができ、具体的には炭酸カリウム、炭酸ナトリウム、炭酸水素カリウム、炭酸水素ナトリウム、水酸化カリウム又は水酸化ナトリウム等が挙げられる。塩基の使用量は、一般式(1)に対するモル比として1〜20、好ましくは3〜8である。また、好ましくは硝酸銀の共存下に実施される。
工程2の反応は、通常、溶媒の存在下に実施される。溶媒としては、ジメチルホルムアミド、ジメチルスルホキシド等の非極性溶媒、ジエチルエーテル、テトラヒドロフラン、ジオキサン等のエーテル系溶媒が通常使用され、その使用量は適宜である。
工程2の反応は、通常0〜200℃、好ましくは50〜150℃の温度で実施され、反応時間は通常1〜50時間、好ましくは3〜30時間である。
<Reaction and reaction conditions in step 2>
The reaction of step 2 is carried out in the presence of a catalyst comprising a transition metal compound and a tri-substituted phosphine and a base.
The transition metal compound is at least one selected from the group consisting of palladium compounds, rhodium compounds, platinum compounds, nickel compounds, cobalt compounds, copper compounds, iron compounds, iridium compounds, ruthenium compounds, silver compounds, and gold compounds. Transition metal compounds are exemplified. The transition metal compound may be a halide, nitrate, acetate, acetylacetonate complex or the like of each compound described above.
Examples of the tri-substituted phosphine include tritert-butylphosphine, trisec-butylphosphine, n-butylphosphine, tripropylphosphine, trihexylphosphine, etc. And triarylphosphine such as tolylphosphine.
Among the transition metal compounds, palladium compounds are preferable from the viewpoint of activity.
As the base, alkali metal carbonates or alkaline earth metal carbonates can be preferably used. Specifically, potassium carbonate, sodium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, potassium hydroxide, sodium hydroxide, etc. Is mentioned. The usage-amount of a base is 1-20 as a molar ratio with respect to General formula (1), Preferably it is 3-8. Further, it is preferably carried out in the presence of silver nitrate.
The reaction of step 2 is usually performed in the presence of a solvent. As the solvent, nonpolar solvents such as dimethylformamide and dimethylsulfoxide, and ether solvents such as diethyl ether, tetrahydrofuran and dioxane are usually used, and the amount used is appropriate.
Reaction of the process 2 is normally implemented at the temperature of 0-200 degreeC, Preferably it is 50-150 degreeC, and reaction time is 1 to 50 hours normally, Preferably it is 3 to 30 hours.
<ピセン及びその誘導体の用途>
本発明で製造されたピセン及びその誘導体は有機半導体、電界効果トランジスタ又は有機薄膜トランジスタ、有機薄膜太陽電池等に用いることができる。
本発明で製造されたピセン及びその誘導体は、ペンタセンよりもイオン化ポテンシャルが低いため化合物の大気中での酸化安定性に優れており、有機半導体として利用する際にはきわめて有利である。
<Uses of picene and its derivatives>
The picene and its derivative manufactured by this invention can be used for an organic semiconductor, a field effect transistor or an organic thin-film transistor, an organic thin-film solar cell, etc.
The picene and its derivatives produced in the present invention have a lower ionization potential than pentacene, so that the oxidation stability of the compound in the atmosphere is excellent, and it is extremely advantageous when used as an organic semiconductor.
次に、本発明の新規化合物について説明する。尚、特に説明しない点については、本発明の製造方法における説明が適宜適用される。
本発明の新規化合物は、下記一般式(1)で表される。
Next, the novel compound of the present invention will be described. In addition, about the point which is not demonstrated especially, the description in the manufacturing method of this invention is applied suitably.
The novel compound of the present invention is represented by the following general formula (1).
上記一般式(1)において、Ar、R5、R6、R7、R8及びX1の表す基としては、本発明の製造方法の工程1における例示と同じものが挙げられる。
また、上記一般式(1)で表される化合物の好ましい化合物及びその製造方法は、上述した通りである。
In the general formula (1), Ar, as the R 5, R 6, R 7 , a group represented by R 8 and X 1, the same thing can be mentioned as illustrative in step 1 of the production method of the present invention.
Moreover, the preferable compound of the compound represented by the said General formula (1) and its manufacturing method are as having mentioned above.
以下に実施例により本発明を具体的に説明する。本発明はこの実施例に限定されない。 The present invention will be specifically described below with reference to examples. The present invention is not limited to this example.
[参考例1]1,4-ジブロモ-2,3-ジヨードベンゼンの合成
[参考例2]TMS-(Z)-アルケニルボロン酸エステルの合成
200mlの二口丸底フラスコに、上記で得られた化合物10(5.5g,19.9mmol)、ビス(トリフェニルホスフィン)パラジウム(II)ジクロライド(Pd(PPh3)2Cl2,140mg,0.2mmol)、ヨウ化銅(190mg,1.0mmol)、トリエチルアミン(70ml)及びトリメチルシリルアセチレン(3.37ml,23.8mmol)をアルゴン雰囲気下で仕込み、室温で12時間攪拌した。トリエチルアミンを減圧留去し、残渣をジエチルエーテルを用いてろ過した。ろ液を減圧留去することで褐色油状物(化合物11,4.5g,収率92%)を得た。
得られた化合物11(4.5g,18.2mmol)をテトラヒドロフラン(50ml)及びメタノール(30ml)の混合溶媒に溶解し、水(1.5ml)に溶解した炭酸カリウム(3.78g,27.3mmol)を添加し、室温で4.5時間攪拌した。反応溶液に飽和塩化アンモニウム水溶液及びジエチルエーテルを加えた。有機層を5%-塩化アンモニウム水溶液及び飽和食塩水で洗浄し、硫酸マグネシウムで乾燥させた。有機層を減圧留去して、フロリジルにより精製することで、褐色油状物(化合物12,2.47g,収率86%)を得た。
50mlのシュレンク管にクロロ(1,5-シクロオクタジエン)ロジウム(I)ダイマー(0.058g,0.12mmol)を仕込んだ後、アルゴンを流した。シクロヘキサン(25ml)、トリイソプロピルフェニル(0.090ml,0.47mmol),トリエチルアミン(6ml)及び4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン(1.14ml,7.85mmol)を連続して加え、15℃にて30分間攪拌した後、上記で得られた化合物12(2.74g,15.7mmol)を一度に加え、室温で攪拌しながら2時間反応させ、その後、メタノールを加えた。反応液をろ過及び減圧留去して、粗生成物を得た。これを蒸留精製して、褐色油状物(化合物13,2.09g,収率88%)を得た。生成物が目的物であることは、1H-NMRで確認した。
[Reference Example 2] Synthesis of TMS- (Z) -alkenylboronic acid ester
In a 200 ml two-necked round bottom flask, compound 10 (5.5 g, 19.9 mmol) obtained above, bis (triphenylphosphine) palladium (II) dichloride (Pd (PPh 3 ) 2 Cl 2 , 140 mg, 0.2 mmol) , Copper iodide (190 mg, 1.0 mmol), triethylamine (70 ml) and trimethylsilylacetylene (3.37 ml, 23.8 mmol) were charged in an argon atmosphere and stirred at room temperature for 12 hours. Triethylamine was distilled off under reduced pressure, and the residue was filtered using diethyl ether. The filtrate was evaporated under reduced pressure to give a brown oil (compound 11,4.5 g, yield 92%).
The obtained compound 11 (4.5 g, 18.2 mmol) was dissolved in a mixed solvent of tetrahydrofuran (50 ml) and methanol (30 ml), potassium carbonate (3.78 g, 27.3 mmol) dissolved in water (1.5 ml) was added, Stir at room temperature for 4.5 hours. A saturated aqueous ammonium chloride solution and diethyl ether were added to the reaction solution. The organic layer was washed with 5% aqueous ammonium chloride solution and saturated brine, and dried over magnesium sulfate. The organic layer was distilled off under reduced pressure and purified by Florisil to obtain a brown oil (compound 12,2.47 g, yield 86%).
A 50 ml Schlenk tube was charged with chloro (1,5-cyclooctadiene) rhodium (I) dimer (0.058 g, 0.12 mmol) and then flushed with argon. Cyclohexane (25 ml), triisopropylphenyl (0.090 ml, 0.47 mmol), triethylamine (6 ml) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.14 ml, 7.85 mmol) in succession. In addition, after stirring at 15 ° C. for 30 minutes, the compound 12 (2.74 g, 15.7 mmol) obtained above was added all at once and reacted at room temperature with stirring for 2 hours, and then methanol was added. The reaction solution was filtered and evaporated under reduced pressure to obtain a crude product. This was purified by distillation to give a brown oil (compound 13,2.09 g, yield 88%). It was confirmed by 1 H-NMR that the product was the desired product.
1H NMR (CDCl3, 300 MHz, rt): δ 0.31 (s, 9H), 1.31 (s, 12H), 5.61 (d, J = 14.7 Hz, 1H), 7.23 (d, J = 14.7 Hz, 1H), 7.26-7.35 (m, 1H), 7.45 (d, J = 9.6 Hz, 1H), 7.56 (d, J = 10.5 Hz, 1H), 7.82 (s, 1H). 1 H NMR (CDCl3, 300 MHz, rt): δ 0.31 (s, 9H), 1.31 (s, 12H), 5.61 (d, J = 14.7 Hz, 1H), 7.23 (d, J = 14.7 Hz, 1H) , 7.26-7.35 (m, 1H), 7.45 (d, J = 9.6 Hz, 1H), 7.56 (d, J = 10.5 Hz, 1H), 7.82 (s, 1H).
[実施例1]
<工程1>1,4-ジブロモ-2,3-ジヨードベンゼンと(Z)-アルケニルボロン酸エステルの鈴木−宮浦カップリング反応
<Step 1> Suzuki-Miyaura coupling reaction of 1,4-dibromo-2,3-diiodobenzene and (Z) -alkenylboronic acid ester
1H NMR (CDCl3, 300 MHz, rt) δ 6.01 (d, J = 12 Hz, 2H), 6,46 (d, J = 12 Hz, 2H),6.92-6.97 (m, 4H), 7.12-7.20 (m, 6H), 7.43 (s, 2H)
FT-IR (KBr, cm-1): 3055 (m), 3024 (m), 1492 (s), 1448 (m), 1427 (m), 1383 (w), 1113 (s), 1026 (m), 960 (m), 868 (m), 839 (m), 804 (s), 772 (m), 750 (m), 692 (s)
MS (EI, m/z (relative intensity)): 440 (M+, 11), 351 (13), 347 (14), 282 (11), 280 (16), 276 (12), 202 (34), 189 (20), 167 (60), 91 (100)
UV-Vis (1.0×10-3g/L, CHCl3): 251nm
1 H NMR (CDCl 3 , 300 MHz, rt) δ 6.01 (d, J = 12 Hz, 2H), 6,46 (d, J = 12 Hz, 2H), 6.92-6.97 (m, 4H), 7.12- 7.20 (m, 6H), 7.43 (s, 2H)
FT-IR (KBr, cm -1 ): 3055 (m), 3024 (m), 1492 (s), 1448 (m), 1427 (m), 1383 (w), 1113 (s), 1026 (m) , 960 (m), 868 (m), 839 (m), 804 (s), 772 (m), 750 (m), 692 (s)
MS (EI, m / z (relative intensity)): 440 (M +, 11), 351 (13), 347 (14), 282 (11), 280 (16), 276 (12), 202 (34), 189 (20), 167 (60), 91 (100)
UV-Vis (1.0 × 10 -3 g / L, CHCl 3 ): 251nm
<工程2>ピセンの合成
1H NMR (CDCl3, 300 MHz, rt) δ 7.68 (q, J = 9 Hz, 2H), 7.74 (q, J = 9 Hz, 2H), 8.00-8.06 (m, 4H), 8.80 (d, J = 9 Hz, 2H), 8.87 (d, J = 9 Hz, 2H), 8.97 (s, 2H)
FT-IR (KBr, cm-1): 1263 (m), 1134 (w), 1024 (w), 945 (w), 806 (s), 754 (s), 738 (s), 526 (m)
MS (EI, m/z (relative intensity)): 278 (M+, 100), 277 (12), 276 (27), 139 (20), 138 (18)
UV-Vis (1.0×10-3g/L, CHCl3, nm): 258, 276, 286, 303, 314, 328
1 H NMR (CDCl 3 , 300 MHz, rt) δ 7.68 (q, J = 9 Hz, 2H), 7.74 (q, J = 9 Hz, 2H), 8.00-8.06 (m, 4H), 8.80 (d, J = 9 Hz, 2H), 8.87 (d, J = 9 Hz, 2H), 8.97 (s, 2H)
FT-IR (KBr, cm -1 ): 1263 (m), 1134 (w), 1024 (w), 945 (w), 806 (s), 754 (s), 738 (s), 526 (m)
MS (EI, m / z (relative intensity)): 278 (M +, 100), 277 (12), 276 (27), 139 (20), 138 (18)
UV-Vis (1.0 × 10 -3 g / L, CHCl 3 , nm): 258, 276, 286, 303, 314, 328
[実施例2]
<工程1>1,4-ジクロロ-2,3-ジヨードベンゼンとTMS-(Z)-アルケニルボロン酸エステルの鈴木−宮浦カップリング反応
<Step 1> Suzuki-Miyaura coupling reaction of 1,4-dichloro-2,3-diiodobenzene and TMS- (Z) -alkenylboronic acid ester
1H NMR (CDCl3, 300 MHz, rt) δ 0.14 (s, 18H), 6.03 (d, J = 12.0 Hz, 2H), 6.53 (d, J = 12.3 Hz, 2H), 7.02 (s, 2H), 7.11 (s, 2H), 7.21 (m, 2H), 7.32-7.35 (m, 4H).13C NMR (CDCl3, 75 MHz, rt) δ -1.39, -1.14, 125.48, 127.71, 128.86, 129.10, 132.30, 132.34, 132.81, 135.94, 137.50, 140.19. 1 H NMR (CDCl 3 , 300 MHz, rt) δ 0.14 (s, 18H), 6.03 (d, J = 12.0 Hz, 2H), 6.53 (d, J = 12.3 Hz, 2H), 7.02 (s, 2H) , 7.11 (s, 2H), 7.21 (m, 2H), 7.32-7.35 (m, 4H). 13 C NMR (CDCl 3 , 75 MHz, rt) δ -1.39, -1.14, 125.48, 127.71, 128.86, 129.10 , 132.30, 132.34, 132.81, 135.94, 137.50, 140.19.
<工程2>3,10-ビス(トリメチルシリル)ピセンの合成
1H NMR (CDCl3, 300 MHz, rt) δ 0.41 (s, 18H), 7.87 (d, J = 9.1 Hz, 2H), 8.04 (d,J = 9.3 Hz, 2H), 8.16 (s, 2H), 8.81 (q, J = 9.0 Hz, 4H), 8.96 (s, 2H).
13C NMR (CDCl3, 75 MHz, rt) δ 0.81, 121.82, 122.37, 127.81, 128.72, 128.89, 128.99, 130.95, 131.32, 131.44, 134.41, 138.96
FT-IR (KBr, cm-1): 1248 (m), 1111 (w), 910 (w), 839 (m), 810 (s), 758 (m).
MS (EI, m/z (relative intensity)): 422 (M+, 100), 409 (13), 408 (36), 407 (85), 196 (49), 73 (62).
UV-Vis: ε = 1.5×105 L・mol-1・cm-1
c = 1.0×10-3 g/L = 2.37×10-6 mol/L. (solvent: CHCl3)
1 H NMR (CDCl 3 , 300 MHz, rt) δ 0.41 (s, 18H), 7.87 (d, J = 9.1 Hz, 2H), 8.04 (d, J = 9.3 Hz, 2H), 8.16 (s, 2H) , 8.81 (q, J = 9.0 Hz, 4H), 8.96 (s, 2H).
13 C NMR (CDCl 3 , 75 MHz, rt) δ 0.81, 121.82, 122.37, 127.81, 128.72, 128.89, 128.99, 130.95, 131.32, 131.44, 134.41, 138.96
FT-IR (KBr, cm -1 ): 1248 (m), 1111 (w), 910 (w), 839 (m), 810 (s), 758 (m).
MS (EI, m / z (relative intensity)): 422 (M +, 100), 409 (13), 408 (36), 407 (85), 196 (49), 73 (62).
UV-Vis: ε = 1.5 × 10 5 L ・ mol -1・ cm -1
c = 1.0 × 10 -3 g / L = 2.37 × 10 -6 mol / L (solvent: CHCl 3 )
[実施例3]
<工程1>1,4-ジクロロ-2,3-ジヨードベンゼンと(Z)-4,4,5,5-テトラメチル-2-(2-フェニル-1-ブテン-1-イル)-1,3,2-ジオキサボロランの鈴木−宮浦カップリング反応
<Step 1> 1,4-Dichloro-2,3-diiodobenzene and (Z) -4,4,5,5-tetramethyl-2- (2-phenyl-1-buten-1-yl) -1 Suzuki-Miyaura coupling reaction of 1,3,2-dioxaborolane
FT-IR (neat, cm-1): 2965 (s), 2929 (s), 2359 (s), 1427 (m), 1150 (m), 806 (w), 772 (m), 698 (s).
1H NMR (CDCl3, 600 MHz, rt) δ 1.04 (t, J = 7.2 Hz, 6H), 2.48-2.54 (m, 4H), 5.46 (s, 2H), 6.91-6.97 (m, 4H), 7.06 (s, 2H), 7.10-7.18 (m, 6H)
13C[1H] NMR (CDCl3, 150 MHz, rt) δ 13.1, 31.1, 122.0, 126.9, 127.6, 127.7, 127.7, 127.8, 127.8, 132.5, 137.9, 140.5.
MS (EI, m/z (relative intensity)): 407 (M+, 7), 406 (24), 377 (26), 289 (24), 252 (23), 119 (43), 117 (40), 105 (39), 91(100).
HRMS (EI) Calcd for C26H24Cl2: 406.1255. Found: 406.1263.
FT-IR (neat, cm -1 ): 2965 (s), 2929 (s), 2359 (s), 1427 (m), 1150 (m), 806 (w), 772 (m), 698 (s) .
1 H NMR (CDCl 3 , 600 MHz, rt) δ 1.04 (t, J = 7.2 Hz, 6H), 2.48-2.54 (m, 4H), 5.46 (s, 2H), 6.91-6.97 (m, 4H), 7.06 (s, 2H), 7.10-7.18 (m, 6H)
13 C [ 1 H] NMR (CDCl 3 , 150 MHz, rt) δ 13.1, 31.1, 122.0, 126.9, 127.6, 127.7, 127.7, 127.8, 127.8, 132.5, 137.9, 140.5.
MS (EI, m / z (relative intensity)): 407 (M +, 7), 406 (24), 377 (26), 289 (24), 252 (23), 119 (43), 117 (40), 105 (39), 91 (100).
HRMS (EI) Calcd for C 26 H 24 Cl 2 : 406.1255. Found: 406.1263.
<工程2>5,8-ジエチルピセンの合成
Mp. > 300 ℃.
FT-IR (KBr, cm-1): 2926 (m), 1452 (w), 1248 (w),1042 (w), 876 (m), 746 (s).
1H NMR (CDCl3, 300 MHz, rt) δ 1.57 (t, J = 8.1 Hz, 6H), 3.35 (q, J = 18 Hz, 4H), 7.66-7.76 (m, 4H), 8.23 (q, J = 6.0 Hz, 2H), 8.65 (s, 2H), 8.87 (s, 2H), 8.91 (q, J = 9.0 Hz, 2H)
13C[1H] NMR (CDCl3, 75 MHz, rt) δ 15.2, 27.1, 120.2, 120.8, 123.7, 124.3, 126.2, 126.4, 127.9, 128.1, 130.9, 131.0, 138.9.
Mp.> 300 ° C.
FT-IR (KBr, cm -1 ): 2926 (m), 1452 (w), 1248 (w), 1042 (w), 876 (m), 746 (s).
1 H NMR (CDCl 3 , 300 MHz, rt) δ 1.57 (t, J = 8.1 Hz, 6H), 3.35 (q, J = 18 Hz, 4H), 7.66-7.76 (m, 4H), 8.23 (q, J = 6.0 Hz, 2H), 8.65 (s, 2H), 8.87 (s, 2H), 8.91 (q, J = 9.0 Hz, 2H)
13 C [ 1 H] NMR (CDCl 3 , 75 MHz, rt) δ 15.2, 27.1, 120.2, 120.8, 123.7, 124.3, 126.2, 126.4, 127.9, 128.1, 130.9, 131.0, 138.9.
[実施例4]
<工程1>1,4-ジクロロ-2,3-ジヨードベンゼンと(Z)-2-(3-メトキシスチリル)-4,4,5,5-テトラメチル-1,3,2-ジオキサボロランの鈴木−宮浦カップリング反応
<Step 1> of 1,4-dichloro-2,3-diiodobenzene and (Z) -2- (3-methoxystyryl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane Suzuki-Miyaura coupling reaction
FT-IR (neat, cm-1): 2938 (w), 1597 (s), 1578 (s), 1489 (s), 1435 (s), 1260 (s), 1153 (m), 1042 (s), 860 (w), 795 (s), 689 (m).
1H NMR (CDCl3, 300 MHz, rt) δ 3.60 (s, 6H), 6.10 (d, = 12 Hz, 2H), 6.49 (d, J = 3.9 Hz, 3H), 6.55 (t, J = 6.6 Hz, 3H), 6.68-6.75 (m, 2H), 7.05-7.10 (m, 2H), 7.31 (s, 2H)
13C[1H] NMR (CDCl3, 75 MHz, rt) δ 54.9, 112.9, 113.6, 119.3, 124.0, 125.6, 128.7, 129.1, 129.2, 132.2, 133.2, 136.0, 137.4, 138.0.
MS (EI, m/z (relative intensity)): 411 (M+, 5), 410 (19), 302 (16), 289 (27), 227 (79), 121 (100), 91 (14).
Anal. Calcd for C24H20Cl2O2: C, 70.08; H, 4.90%. Found: C, 69.93; H, 4.78%.
FT-IR (neat, cm -1 ): 2938 (w), 1597 (s), 1578 (s), 1489 (s), 1435 (s), 1260 (s), 1153 (m), 1042 (s) , 860 (w), 795 (s), 689 (m).
1 H NMR (CDCl 3 , 300 MHz, rt) δ 3.60 (s, 6H), 6.10 (d, = 12 Hz, 2H), 6.49 (d, J = 3.9 Hz, 3H), 6.55 (t, J = 6.6 Hz, 3H), 6.68-6.75 (m, 2H), 7.05-7.10 (m, 2H), 7.31 (s, 2H)
13 C [ 1 H] NMR (CDCl 3 , 75 MHz, rt) δ 54.9, 112.9, 113.6, 119.3, 124.0, 125.6, 128.7, 129.1, 129.2, 132.2, 133.2, 136.0, 137.4, 138.0.
MS (EI, m / z (relative intensity)): 411 (M +, 5), 410 (19), 302 (16), 289 (27), 227 (79), 121 (100), 91 (14).
Anal. Calcd for C 24 H 20 Cl 2 O 2 : C, 70.08; H, 4.90%. Found: C, 69.93; H, 4.78%.
<工程2>3,10-ジメトキシピセンの合成
Mp. > 300 ℃.
FT-IR (KBr, cm-1): 2930 (w), 1522 (m), 1450 (s), 1427 (s), 1269 (s), 1238 (s), 1140 (s), 1059 (s), 841 (s), 820 (s), 748 (s), 704 (w).
1H NMR (CDCl3, 600 MHz, rt) δ 4.21 (s, 6H), 7.21 (q, J = 12 Hz, 2H), 7.58-7.64 (m, 4H), 7.96 (d, J = 9.6 Hz, 2H), 8.83 (d, J = 9.0 Hz, 2H), 9.92 (s, 2H)
13C[1H] NMR (CDCl3, 150 MHz, rt) δ 55.9, 108.2, 121.1, 121.4, 122.5, 126.5, 126.6, 127.1, 128.5, 128.8, 134.3, 158.9.
Mp.> 300 ° C.
FT-IR (KBr, cm -1 ): 2930 (w), 1522 (m), 1450 (s), 1427 (s), 1269 (s), 1238 (s), 1140 (s), 1059 (s) , 841 (s), 820 (s), 748 (s), 704 (w).
1 H NMR (CDCl 3 , 600 MHz, rt) δ 4.21 (s, 6H), 7.21 (q, J = 12 Hz, 2H), 7.58-7.64 (m, 4H), 7.96 (d, J = 9.6 Hz, 2H), 8.83 (d, J = 9.0 Hz, 2H), 9.92 (s, 2H)
13 C [ 1 H] NMR (CDCl 3 , 150 MHz, rt) δ 55.9, 108.2, 121.1, 121.4, 122.5, 126.5, 126.6, 127.1, 128.5, 128.8, 134.3, 158.9.
[実施例5]
<工程1>1,4-ジクロロ-2,3-ジヨードベンゼンと(Z)-2-(2,4-ジメトキシスチリル)-4,4,5,5-テトラメチル-1,3,2-ジオキサボロランの鈴木−宮浦カップリング反応
<Step 1> 1,4-Dichloro-2,3-diiodobenzene and (Z) -2- (2,4-dimethoxystyryl) -4,4,5,5-tetramethyl-1,3,2- Suzuki-Miyaura coupling reaction of dioxaborolane
FT-IR (neat, cm-1): 2938 (w), 1608 (s), 1503 (s), 1464 (w), 1292 (s), 1290 (s), 1159, (s), 823 (w).
1H NMR (CDCl3, 300 MHz, rt) δ 3.76 (s, 6H), 3.80 (s, 6H), 6.17 (q, J = 8.7 Hz, 2H), 6.36 (s, 2H), 6.57 (q, J = 7.5 Hz, 2H), 6.78 (d, J = 12 Hz, 2H), 7.23 (s, 2H), 7.29 (s, 2H)
13C[1H] NMR (CDCl3, 75 MHz, rt) δ 55.0, 55.4, 98.1, 104.1, 119.0, 123.5, 128.5, 128.9, 131.9, 137.9, 157.9, 160.3.
MS (EI, m/z (relative intensity)): 471 (M+, 7), 470 (26), 332 (12), 151 (100), 121 (16).
HRMS (EI) Calcd for C26H24Cl2O4: 470.1052. Found: 470.1043.
FT-IR (neat, cm -1 ): 2938 (w), 1608 (s), 1503 (s), 1464 (w), 1292 (s), 1290 (s), 1159, (s), 823 (w ).
1 H NMR (CDCl 3 , 300 MHz, rt) δ 3.76 (s, 6H), 3.80 (s, 6H), 6.17 (q, J = 8.7 Hz, 2H), 6.36 (s, 2H), 6.57 (q, J = 7.5 Hz, 2H), 6.78 (d, J = 12 Hz, 2H), 7.23 (s, 2H), 7.29 (s, 2H)
13 C [ 1 H] NMR (CDCl 3 , 75 MHz, rt) δ 55.0, 55.4, 98.1, 104.1, 119.0, 123.5, 128.5, 128.9, 131.9, 137.9, 157.9, 160.3.
MS (EI, m / z (relative intensity)): 471 (M +, 7), 470 (26), 332 (12), 151 (100), 121 (16).
HRMS (EI) Calcd for C 26 H 24 Cl 2 O 4 : 470.1052. Found: 470.1043.
<工程2>2,4,9,11-テトラメトキシピセンの合成
Mp. > 300℃.
FT-IR (KBr, cm-1): 2999 (w), 1618 (s), 1454 (m), 1416 (m), 1383 (m), 1261 (s), 1148 (s), 1047 (s), 808 (m), 644 (w).
1H NMR (CDCl3, 600 MHz, rt) δ 4.06 (s, 6H), 4.08 (s, 6H), 6.70 (d, J = 2.4 Hz, 2H), 7.73 (d, J = 1.8 Hz, 2H), 8.37 (d, J = 9.6 Hz, 2H), 8.64 (d, J = 9.0 Hz, 2H), 8.74 (s, 2H)
13C[1H] NMR (CDCl3, 150 MHz, rt) δ 55.7, 56.0, 95.5, 97.9, 118.9, 119.2, 121.1, 121.6, 127.9, 129.8, 132.6, 157.3, 159.3.
HRMS (EI) Calcd for C26H22O4: 398.1518, Found: 398.1502.
Mp.> 300 ° C.
FT-IR (KBr, cm -1 ): 2999 (w), 1618 (s), 1454 (m), 1416 (m), 1383 (m), 1261 (s), 1148 (s), 1047 (s) , 808 (m), 644 (w).
1 H NMR (CDCl 3 , 600 MHz, rt) δ 4.06 (s, 6H), 4.08 (s, 6H), 6.70 (d, J = 2.4 Hz, 2H), 7.73 (d, J = 1.8 Hz, 2H) , 8.37 (d, J = 9.6 Hz, 2H), 8.64 (d, J = 9.0 Hz, 2H), 8.74 (s, 2H)
13 C [ 1 H] NMR (CDCl 3 , 150 MHz, rt) δ 55.7, 56.0, 95.5, 97.9, 118.9, 119.2, 121.1, 121.6, 127.9, 129.8, 132.6, 157.3, 159.3.
HRMS (EI) Calcd for C 26 H 22 O 4 : 398.1518, Found: 398.1502.
[実施例6]
<工程1>1,4-ジクロロ-2,3-ジヨードベンゼンと(Z)-2-(3-デシルスチリル)-4,4,5,5-テトラメチル-1,3,2-ジオキサボロランの鈴木−宮浦カップリング反応
<Step 1> Suzuki of 1,4-dichloro-2,3-diiodobenzene and (Z) -2- (3-decylstyryl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane -Miyaura coupling reaction
FT-IR (neat, cm-1): 2924 (s), 2853 (s), 2357 (w), 1600 (w), 1456 (m), 1435 (m), 1128 (m), 903 (w), 804 (s), 696 (s).
1H NMR (CDCl3, 300 MHz, rt) δ 0.87-0.91 (m, 6H), 1.26-1.31 (m, 32H), 2.43 (t, J = 7.7 Hz, 4H), 6.00 (d, J = 12.0 Hz, 2H), 6.49 (d, J = 12.0 Hz, 2H), 6.77 (d, J = 12.0 Hz, 4H), 6.96 (d, J = 7.5 Hz, 2H), 7.07 (t, J = 7.5 Hz, 2), 7.29 (s, 2H)
13C[1H] NMR (CDCl3, 75 MHz, rt) δ 14.1, 22.7, 29.2, 29.4, 29.5, 29.6, 29.7, 31.2, 31.9, 35.7, 125.3, 125.4, 125.7, 128.0, 128.1, 128.1, 129.0, 132.2, 136.7, 137.5, 142.7.
FT-IR (neat, cm -1 ): 2924 (s), 2853 (s), 2357 (w), 1600 (w), 1456 (m), 1435 (m), 1128 (m), 903 (w) , 804 (s), 696 (s).
1 H NMR (CDCl 3 , 300 MHz, rt) δ 0.87-0.91 (m, 6H), 1.26-1.31 (m, 32H), 2.43 (t, J = 7.7 Hz, 4H), 6.00 (d, J = 12.0 Hz, 2H), 6.49 (d, J = 12.0 Hz, 2H), 6.77 (d, J = 12.0 Hz, 4H), 6.96 (d, J = 7.5 Hz, 2H), 7.07 (t, J = 7.5 Hz, 2), 7.29 (s, 2H)
13 C [ 1 H] NMR (CDCl 3 , 75 MHz, rt) δ 14.1, 22.7, 29.2, 29.4, 29.5, 29.6, 29.7, 31.2, 31.9, 35.7, 125.3, 125.4, 125.7, 128.0, 128.1, 128.1, 129.0 , 132.2, 136.7, 137.5, 142.7.
<工程2>3,10-ジデシルピセンの合成
Mp. > 300℃.
FT-IR (KBr, cm-1): 1713 (w), 1466 (w), 1263 (w), 1096 (m), 785 (m), 507 (m).
1H NMR (CDCl3, 600 MHz, rt) δ 0.86-0.89 (m, 6H), 1.25-1.44 (m, 28H), 1.75-1.80 (m, 4H), 2.86 (t, 4H), 7,58 (q, J = 6 Hz, 2H), 7.78 (s, 2H), 7.97 (d, J = 9.0 Hz, 2H), 8.75 (q, J = 12 Hz, 4H), 8.90 (s, 2H)
13C[1H] NMR (CDCl3, 150 MHz, rt) δ 14.1, 22.7, 29.3, 29.4, 29.6, 29.6, 29.6, 31.5, 31.9, 35.9, 121.5, 121.6, 123.0, 127.2, 127.3, 128.0, 128.2, 128.5, 128.7, 132.0, 141.3.
Mp.> 300 ° C.
FT-IR (KBr, cm -1 ): 1713 (w), 1466 (w), 1263 (w), 1096 (m), 785 (m), 507 (m).
1 H NMR (CDCl 3 , 600 MHz, rt) δ 0.86-0.89 (m, 6H), 1.25-1.44 (m, 28H), 1.75-1.80 (m, 4H), 2.86 (t, 4H), 7,58 (q, J = 6 Hz, 2H), 7.78 (s, 2H), 7.97 (d, J = 9.0 Hz, 2H), 8.75 (q, J = 12 Hz, 4H), 8.90 (s, 2H)
13 C [ 1 H] NMR (CDCl 3 , 150 MHz, rt) δ 14.1, 22.7, 29.3, 29.4, 29.6, 29.6, 29.6, 31.5, 31.9, 35.9, 121.5, 121.6, 123.0, 127.2, 127.3, 128.0, 128.2 , 128.5, 128.7, 132.0, 141.3.
[実施例7]
<工程1>1,4-ジクロロ-2,3-ジヨードベンゼンと(Z)-4,4,5,5-テトラメチル-2-(2-(チオフェン-3-イル)ビニル)-1,3,2-ジオキサボロランの鈴木−宮浦カップリング反応
<Step 1> 1,4-Dichloro-2,3-diiodobenzene and (Z) -4,4,5,5-tetramethyl-2- (2- (thiophen-3-yl) vinyl) -1, Suzuki-Miyaura coupling reaction of 3,2-dioxaborolane
FT-IR (neat, cm-1): 2926 (s), 1724 (s), 1634 (w), 1435 (s), 1281 (s), 1265 (m), 1125 (s), 870 (m), 797 (s), 773 (m).
1H NMR (300 MHz, 25 oC, CDCl3): 6.08 (d, J = 12.0 Hz, 2H), 6.56-6.60 (m, 4H), 6.91 (d, J = 2.4 Hz, 2H), 7.09-7.11 (m, 2H), 7.37 (s, 1H).
13C[1H] NMR (75 MHz, 25 oC, CDCl3): 124.0, 124.3, 125.4, 126.4, 127.0, 129.4, 132.3, 137.8, 138.0
MS (EI, m/z (relative intensity)): 363 (M+, 11), 362 (15), 280 (11), 278 (16), 267 (17), 265 (25), 258 (11), 208 (14), 179 (40), 97 (100).
FT-IR (neat, cm -1 ): 2926 (s), 1724 (s), 1634 (w), 1435 (s), 1281 (s), 1265 (m), 1125 (s), 870 (m) , 797 (s), 773 (m).
1 H NMR (300 MHz, 25 oC, CDCl 3 ): 6.08 (d, J = 12.0 Hz, 2H), 6.56-6.60 (m, 4H), 6.91 (d, J = 2.4 Hz, 2H), 7.09-7.11 (m, 2H), 7.37 (s, 1H).
13 C [ 1 H] NMR (75 MHz, 25 oC, CDCl 3 ): 124.0, 124.3, 125.4, 126.4, 127.0, 129.4, 132.3, 137.8, 138.0
MS (EI, m / z (relative intensity)): 363 (M +, 11), 362 (15), 280 (11), 278 (16), 267 (17), 265 (25), 258 (11), 208 (14), 179 (40), 97 (100).
<工程2>5,8-ジエチルピセンの合成
m.p. 242-248℃
FT-IR (KBr, cm-1): 1564 (w), 1385 (w), 1292 (s), 1088 (m), 814 (s), 802 (s), 687 (s), 590 (w).
1H NMR (300 MHz, 25 oC, CDCl3): 7.56 (dd, J = 12.9, 5.4Hz 4H), 8.06 (d, J = 9.0 Hz, 2H), 8.23 (s, 2H), 8.69 (d, J = 9.0 Hz, 2H).
13C[1H] NMR (150 MHz, 25 oC, CDCl3): 120.4, 122.7, 123.7, 125.1, 125.8, 127.1, 127.7, 137.8, 138.9.
MS (EI, m/z (relative intensity)): 290 (M+, 98), 289 (36), 258 (59), 243 (28), 209 (20), 207 (21), 145 (100), 127 (25), 99 (22), 82 (21).
Anal. Calcd for C18H10S2: C, 74.45; H, 3.47%. Found: C, 74.52; H, 3.47%.
mp 242-248 ℃
FT-IR (KBr, cm -1 ): 1564 (w), 1385 (w), 1292 (s), 1088 (m), 814 (s), 802 (s), 687 (s), 590 (w) .
1 H NMR (300 MHz, 25 oC, CDCl 3 ): 7.56 (dd, J = 12.9, 5.4Hz 4H), 8.06 (d, J = 9.0 Hz, 2H), 8.23 (s, 2H), 8.69 (d, J = 9.0 Hz, 2H).
13 C [ 1 H] NMR (150 MHz, 25 oC, CDCl 3 ): 120.4, 122.7, 123.7, 125.1, 125.8, 127.1, 127.7, 137.8, 138.9.
MS (EI, m / z (relative intensity)): 290 (M +, 98), 289 (36), 258 (59), 243 (28), 209 (20), 207 (21), 145 (100), 127 (25), 99 (22), 82 (21).
Anal. Calcd for C 18 H 10 S 2 : C, 74.45; H, 3.47%. Found: C, 74.52; H, 3.47%.
得られた化合物8、化合物16、化合物19、化合物No.22、化合物25、化合物28及び化合物31は、公知の方法と同様にして、素子の製造が可能であり、同様の性能を示すことが確認できた。 The obtained compound 8, compound 16, compound 19, compound no. It was confirmed that the compound No. 22, compound 25, compound 28 and compound 31 can be produced in the same manner as in the known method and show the same performance.
Claims (10)
下記一般式(1)で表される化合物(a)を脱ハロゲン化水素させる工程2とを含むことを特徴とする下記一般式(4)で表されるピセン及びその誘導体の製造方法。
(式中、X1及びX2はハロゲン原子を示し、R7及びR8はそれぞれ独立に水素原子、ハロゲン原子、ニトロ基、水酸基、炭素数1〜20のアルキルカルボニルオキシ基、炭素数1〜20の置換基を有していてもよいアミノ基、カルボキシル基、塩基と塩を形成しているカルボキシル基、アルコールと炭素数1〜20のエステルを形成しているカルボキシル基、置換基を有していてもよい炭素数1〜20の炭化水素基、置換基を有していてもよい炭素数1〜20のアルコキシ基又は−SiR13R14R15で表される基を示し、R13、R14及びR15はそれぞれ独立に水素原子又は置換基を有していてもよい炭素数1〜20の炭化水素基を示す。)
(式中、Arは、アリール基を表し、Ar中の水素原子は、ハロゲン原子、ニトロ基、水酸基、炭素数1〜20のアルキルカルボニルオキシ基、炭素数1〜20の置換基を有していてもよいアミノ基、カルボキシル基、塩基と塩を形成しているカルボキシル基、アルコールと炭素数1〜20のエステルを形成しているカルボキシル基、置換基を有していてもよい炭素数1〜20の炭化水素基、置換基を有していてもよい炭素数1〜20のアルコキシ基又は−SiR13R14R15により置換されていてもよく、R5及びR6はそれぞれ独立に水素原子、ハロゲン原子、ニトロ基、水酸基、炭素数1〜20のアルキルカルボニルオキシ基、炭素数1〜20の置換基を有していてもよいアミノ基、カルボキシル基、塩基と塩を形成しているカルボキシル基、アルコールと炭素数1〜20のエステルを形成しているカルボキシル基、置換基を有していてもよい炭素数1〜20の炭化水素基、置換基を有していてもよい炭素数1〜20のアルコキシ基又は−SiR13R14R15で表される基を示し、R11及びR12はそれぞれ独立に水素原子又は炭素数1〜20のアルコキシ基を示し、R11及びR12は環を形成していてもよく、R13、R14及びR15はそれぞれ独立に水素原子又は置換基を有していてもよい炭素数1〜20の炭化水素基を示す。)
(式中、X1はハロゲン原子を示し、Ar、R5及びR6は上記一般式(3)と同一であり
、R7及びR8は上記一般式(2)と同一であり、2つあるAr、R5又はR6は互いに異なっていてもよく、Ar中の水素原子は、上記一般式(3)と同様に置換されていてもよい。)
(式中、Ar、R5及びR6は上記一般式(3)と同一であり、2つあるAr、R5又はR6は互いに異なっていてもよく、Ar中の水素原子は、上記一般式(3)と同様に置換されていてもよい。) A compound represented by the following general formula (1) by coupling the compound (b) represented by the following general formula (2) and the compound (c) represented by the following general formula (3). Step 1 for producing (a);
And a process 2 for dehydrohalogenating the compound (a) represented by the following general formula (1), and a method for producing a picene represented by the following general formula (4) and a derivative thereof.
(In the formula, X 1 and X 2 each represent a halogen atom, and R 7 and R 8 each independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, an alkylcarbonyloxy group having 1 to 20 carbon atoms, or 1 to 1 carbon atoms. 20 substituent amino group which may have a carboxyl group, a carboxyl group forming salts with bases, Luke carboxyl group to form an ester with an alcohol having 1 to 20 carbon atoms, have a substituent Indication of hydrocarbon groups having 1 to 20 carbon atoms which may have a group represented by an alkoxy group or a -SiR 13 R 14 R 15 having 1 to 20 carbon atoms that may have a substituent, R 13 R 14 and R 15 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms which may have a substituent.
(In the formula, Ar represents an aryl group, and the hydrogen atom in Ar has a halogen atom, a nitro group, a hydroxyl group, an alkylcarbonyloxy group having 1 to 20 carbon atoms, and a substituent having 1 to 20 carbon atoms. an amino group which may be a carboxyl group, a carboxyl group forming salts with bases, alcohols and esters formed have Luke carboxyl group having 1 to 20 carbon atoms, carbon atoms which may have a substituent 1 May be substituted with a hydrocarbon group having ˜20, an alkoxy group having 1 to 20 carbon atoms which may have a substituent, or —SiR 13 R 14 R 15 , and R 5 and R 6 are each independently hydrogen. Forms a salt with an atom, a halogen atom, a nitro group, a hydroxyl group, an alkylcarbonyloxy group having 1 to 20 carbon atoms, an amino group that may have a substituent having 1 to 20 carbon atoms, a carboxyl group, or a base Carboxy Group, to form an ester with an alcohol having 1 to 20 carbon atoms Luke carboxyl group, optionally substituted hydrocarbon group having 1 to 20 carbon atoms carbon atoms, which may have a substituent 1 to 20 alkoxy groups or a group represented by —SiR 13 R 14 R 15 , R 11 and R 12 each independently represent a hydrogen atom or an alkoxy group having 1 to 20 carbon atoms, and R 11 and R 12 May form a ring, and R 13 , R 14 and R 15 each independently represent a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms which may have a substituent.
(Wherein X 1 represents a halogen atom, Ar, R 5 and R 6 are the same as in the above general formula (3), R 7 and R 8 are the same as in the above general formula (2), Ar, R 5 or R 6 may be different from each other, and the hydrogen atom in Ar may be substituted in the same manner as in the general formula (3).
(In the formula, Ar, R 5 and R 6 are the same as in the general formula (3), two Ar, R 5 or R 6 may be different from each other, and the hydrogen atom in Ar is (It may be substituted in the same manner as in formula (3).)
(式中、X1はハロゲン原子を示し、Ar、R5及びR6は上記一般式(3)と同一であり
、R7及びR8は上記一般式(2)と同一であり、2つあるAr、R5又はR6は互いに異なっていてもよく、Ar中の水素原子は、上記一般式(3)と同様に置換されていてもよい。) A compound represented by the following general formula (1).
(Wherein X 1 represents a halogen atom, Ar, R 5 and R 6 are the same as in the above general formula (3), R 7 and R 8 are the same as in the above general formula (2), Ar, R 5 or R 6 may be different from each other, and the hydrogen atom in Ar may be substituted in the same manner as in the general formula (3).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013101582A JP6132656B2 (en) | 2012-05-22 | 2013-05-13 | Method for producing picene and derivatives thereof |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012116733 | 2012-05-22 | ||
JP2012116733 | 2012-05-22 | ||
JP2012184377 | 2012-08-23 | ||
JP2012184377 | 2012-08-23 | ||
JP2013101582A JP6132656B2 (en) | 2012-05-22 | 2013-05-13 | Method for producing picene and derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014058501A JP2014058501A (en) | 2014-04-03 |
JP6132656B2 true JP6132656B2 (en) | 2017-05-24 |
Family
ID=50615331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013101582A Expired - Fee Related JP6132656B2 (en) | 2012-05-22 | 2013-05-13 | Method for producing picene and derivatives thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6132656B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10074804B2 (en) * | 2014-10-21 | 2018-09-11 | Adeka Corporation | Picene derivative, photoelectric material, and photoelectric device |
CA3090816A1 (en) * | 2018-03-05 | 2019-09-12 | Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno | Polycyclic aromatic compounds and methods for making and using the same |
CN114478154B (en) * | 2022-02-25 | 2023-11-21 | 西安欧得光电材料有限公司 | Industrial synthesis method of picene |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2010016511A1 (en) * | 2008-08-08 | 2012-01-26 | 出光興産株式会社 | Compound for organic thin film transistor and organic thin film transistor using the same |
TW201016637A (en) * | 2008-08-29 | 2010-05-01 | Idemitsu Kosan Co | Compound for organic thin film transistor and organic thin film transistor using same |
CN102137830A (en) * | 2008-08-29 | 2011-07-27 | 出光兴产株式会社 | Compound for organic thin film transistor and organic thin film transistor using the same |
CN102264698B (en) * | 2008-12-23 | 2015-11-25 | 株式会社Luminano | Novel organic semi-conductor compound, its manufacture method and organic semiconductor composition, organic semiconductor thin film and element containing it |
JP5765559B2 (en) * | 2010-06-15 | 2015-08-19 | 株式会社リコー | Substituent leaving compound and organic semiconductor material obtained therefrom, organic electronic device, organic thin film transistor and display device using the same |
-
2013
- 2013-05-13 JP JP2013101582A patent/JP6132656B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2014058501A (en) | 2014-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6386888B2 (en) | Complex compound | |
JP6132656B2 (en) | Method for producing picene and derivatives thereof | |
Paixao et al. | Copper salt-catalyzed homo-coupling reaction of potassium alkynyltrifluoroborates: a simple and efficient synthesis of symmetrical 1, 3-diynes | |
Singh et al. | Synthesis of symmetrical 1, 3-diynes via homocoupling reaction of n-butyl alkynyltellurides | |
Bora et al. | Novel CuCl2-cryptand-[2.2. Benzo] complex: A base free and oxidant free catalyst for Ipso-Hydroxylation of aryl/heteroaryl-boronic acids in water at room temperature | |
Son et al. | Functional group compatible palladium-catalyzed cross-coupling reactions between aryllithium and aryl halide mediated by a five-membered cyclic silyl ether | |
JP5963167B2 (en) | Method for producing organic dye MK-2 | |
JP5288779B2 (en) | 2,3-dicyanonaphthalene derivative | |
Maekawa et al. | Regioselective coupling reaction of azulene with α, β-unsaturated ketones by Mg-promoted reduction | |
Muniyappan et al. | Synthesis, structure and characterization of picolyl and benzyl linked biphenyl nickel NHC complexes and their catalytic activity in Suzuki-Miyaura cross-coupling reactions | |
Omote et al. | New axially dissymmetric ligand recoverable with fluorous solvent | |
Fujita et al. | Suzuki–Miyaura reaction catalyzed by a dendritic phosphine–palladium complex | |
Klein et al. | Convenient synthesis of tridentate 2, 6-di (pyrazol-1-yl)-4-carboxypyridine and tetradentate 6, 6′-di (pyrazol-1-yl)-4, 4′-dicarboxy-2, 2′-bipyridine ligands | |
JP5207516B2 (en) | Method for producing 2,3-dicyanonaphthalene derivative | |
Singh et al. | Synthesis and characterization of novel trifluoromethyl-containing alcohols with Ruppert's reagent | |
Wu et al. | Hydrogen bonding-mediated self-assembly of square and triangular metallocyclophanes | |
CN111018691B (en) | Green synthesis method of aromatic acid | |
CN103242176B (en) | Based on the functional ion liquid and preparation method thereof of choline chloride 60 | |
Toyota et al. | Unexpected formation of 4, 7-dihalobenzo [b] thiophenes using Ohira-Bestmann reagent and reactivity of the halogen-substituted benzo [b] thiophenes in Suzuki-Miyaura coupling with phenylboronic acid | |
JP5407332B2 (en) | Method for producing quarterpyridine derivative and its intermediate | |
Amosova et al. | Reactions of selenourea with benzoyl-and 2-thienoylbromoacetylenes: synthesis of 1, 3-diselenetanes and 1, 4-diselenafulvenes | |
JP6306874B2 (en) | Method for producing bromine compound | |
Tanaka et al. | 1, 3-Diiodocalix [4] arene: Synthesis by Ullmann-Type Iodination of 1, 3-Bistriflate Ester of Calix [4] arene, Conformational Analysis, and Transformation into 1, 3-Dicarboxy-, Diformyl-, and Dialkylcalix [4] arenes | |
JP6233918B2 (en) | Poly (3-substituted thiophene) compounds, synthetic intermediates thereof, and methods for producing them | |
Chang et al. | Tandem Cyclization in Ruthenium Vinylidene Complexes with Two Ester Groups |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20160119 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160323 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161208 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170217 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20170217 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170307 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170315 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170411 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170418 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6132656 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |